Skip to main content

Day: July 23, 2020

Amplify Energy Announces Second Quarter 2020 Earnings Conference Call

HOUSTON, July 23, 2020 (GLOBE NEWSWIRE) — Amplify Energy Corp. (“Amplify” or the “Company”) (NYSE: AMPY) announced today that it will report second quarter 2020 financial and operating results on August 5, 2020. Following the announcement, management will host a conference call at 10:00 a.m. CT to discuss the Company’s results. Interested parties are invited to participate in the conference call by dialing (833) 883-4379 (Conference ID: 4185547) at least 15 minutes prior to the start of the call or via the internet at www.amplifyenergy.com. A replay of the call will be available on Amplify’s website or by phone at (855) 859-2056 (Conference ID: 4185547) for a fourteen-day period following the call.About Amplify EnergyAmplify Energy Corp. is an independent oil and natural gas company engaged in the acquisition, development, exploration...

Continue reading

CORRECTION — Surrey Bancorp Reports Second Quarter Net Income of $971,563

MOUNT AIRY, N.C., July 23, 2020 (GLOBE NEWSWIRE) — In a press release issued under the same headline earlier today by Surrey Bancorp (Pink Sheets: SRYB), please note that the Total loans figure in the Consolidated Financial Highlights table under the June 30, 2020 (unaudited) column should be 280,201, not 347,135. The corrected release follows:Surrey Bancorp (the “Company”), (Pink Sheets: SRYB), the holding company for Surrey Bank & Trust, today reported earnings for the second quarter of 2020.For the quarter ended June 30, 2020, net income totaled $971,563 or $0.23 per fully diluted share, compared to $1,165,651 or $0.28 per fully diluted common share earned during the second quarter of 2019. Net interest income decreased from $3,338,262 in the second quarter of 2019 to $2,877,332 in the second quarter of 2020. The decrease...

Continue reading

Equity Bancshares, Inc. Announces Completion of Additional $33 Million Subordinated Notes Offering, Raising a Total of $75 Million

WICHITA, Kan., July 23, 2020 (GLOBE NEWSWIRE) — Equity Bancshares, Inc. (NASDAQ: EQBK), (“Equity”, “we”, “us”, “our”), the Wichita-based holding company of Equity Bank, announced the issuance of $33 million aggregate principal amount of fixed-to-floating rate subordinated notes due 2030 (the “Notes”) to certain institutional accredited investors and qualified institutional buyers in a private placement transaction. The offering of the Notes is a further issuance of the 7.00% Fixed-to-Floating Rate Subordinated Notes, due 2030, issued on June 29, 2020, and form a single series with and are identical in all material respects to the $42.0 million aggregate principal amount of outstanding notes.The Notes are intended to qualify as Tier 2 capital for regulatory capital purposes.  The Notes will initially bear interest at a fixed annual...

Continue reading

Titanium Transportation Group Will Hold a Conference Call to Discuss its Second Quarter Results

BOLTON, Ontario, July 23, 2020 (GLOBE NEWSWIRE) — Titanium Transportation Group Inc. (“Titanium” or the “Company”) (TSX VENTURE:TTR) is pleased to announce that it will issue its financial results for the second quarter ended June 30, 2020 via news release on Tuesday, August 11, 2020 after market close.The Company will also hold a conference call for analysts and investors with Ted Daniel, President and Chief Executive Officer, on Wednesday, August 12, 2020, at 8:00 a.m. Eastern Time, to discuss these results. Business media are also invited to listen to the call.Details of the conference call:Date: Wednesday, August 12, 2020Time: 8:00 a.m. Eastern TimeNorth America dial-in number: 1-877-291-4570International dial-in number: 1-647-788-4919A replay of the conference call can be accessed until midnight on August...

Continue reading

Codorus Valley Bancorp, Inc. Reports Second Quarter 2020 Earnings

YORK, Pa., July 23, 2020 (GLOBE NEWSWIRE) — Codorus Valley Bancorp, Inc. (Codorus Valley, or the Corporation) (NASDAQ: CVLY), parent company of PeoplesBank, A Codorus Valley Company (PeoplesBank), collectively referred to as the Company, today announced net income of $3.1 million or $0.31 per share basic and diluted, for the quarter ended June 30, 2020, as compared to net income of $4.9 million or $0.49 per share basic and diluted, for the quarter ended June 30, 2019.  For the first six months of 2020, net income was $61,000 or $0.01 per share basic and diluted, compared to $9.0 million or $0.90 per share basic and diluted, for the first six months of 2019.“Earnings for the second quarter 2020 were adversely affected by an increase in the provision for loan and lease losses associated with the COVID-19 pandemic and due to a loan...

Continue reading

Yamana Gold Reports Second Quarter 2020 Financial Results; Strong Cash Flow Generation; a Further Reduction of $101 Million in Net Debt; Jacobina Phase 1 Expansion Complete; Increasing Dividend by a Further 12% to $0.07 Per Share

TORONTO, July 23, 2020 (GLOBE NEWSWIRE) — YAMANA GOLD INC. (TSX:YRI; NYSE:AUY) (“Yamana” or “the Company”) is herein reporting its financial and operational results for the second quarter of 2020. The Company posted strong quarterly production and free cash flow while further reducing net debt.    SECOND QUARTER HIGHLIGHTSStrong Adjusted Net Earnings and Cash Flows, Further Reduction in Net DebtAdjusted net earnings(1) of $63.3 million or $0.07 per share basic and diluted compared to adjusted net earnings of $19.8 million or $0.02 per share basic and diluted a year earlier.Net earnings were nil or nil per share basic and diluted compared to net earnings of $14.1 million or $0.01 per share basic and diluted a year earlier.(1)Strong quarterly cash flows from operating activities of $92.2 million and cash flow from operating activities...

Continue reading

FS Bancorp, Inc. Reports Net Income for the Second Quarter of $10.0 Million or $2.30 Per Diluted Share, and Thirtieth Consecutive Quarterly Dividend

MOUNTLAKE TERRACE, Wash., July 23, 2020 (GLOBE NEWSWIRE) — FS Bancorp, Inc. (NASDAQ:FSBW) (the “Company”), the holding company for 1st Security Bank of Washington (the “Bank”) today reported 2020 second quarter net income of $10.0 million, or $2.30 per diluted share, compared to $4.5 million, or $0.98 per diluted share for the same period last year.“During the last eight years of significant growth, we focused on maintaining diversified revenue streams through challenging economic environments.  The results of the second quarter reflect our diversified strategy and commitment to long-term shareholder value as we surpassed the $2 billion in assets mark this quarter,” stated Joe Adams, CEO.  “We are also pleased to announce that our Board of Directors has approved our thirtieth consecutive quarterly cash dividend. The quarterly dividend...

Continue reading

Silk Road Medical to Report Second Quarter 2020 Financial Results on August 5, 2020

SUNNYVALE, Calif., July 23, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the second quarter 2020 after market close on Wednesday, August 5, 2020. Company management will host a corresponding conference call beginning at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.Investors interested in listening to the conference call may do so by dialing (844) 883-3861 for domestic callers or (574) 990-9820 for international callers, using conference ID: 3681776. A live and archived webcast of the event will be available at https://investors.silkroadmed.com/.    About Silk Road MedicalSilk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, that is...

Continue reading

Cobomarsen Receives Orphan Drug Designation From the U.S. FDA for the Treatment of T-cell Lymphoma

BOULDER, Colo., July 23, 2020 (GLOBE NEWSWIRE) — miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that the Food & Drug Administration (FDA) has granted orphan drug designation to cobomarsen, for the treatment of T-cell lymphoma. Cobomarsen is an inhibitor of miR-155 currently being developed by miRagen in two clinical programs to address different types of T-cell lymphoma, including a Phase 2 trial for cutaneous T-cell lymphoma (CTCL) and a Phase 1 trial for adult T-cell leukemia/lymphoma (ATLL).“This is an important milestone in the development of cobomarsen. We believe the FDA’s decision to grant cobomarsen orphan drug designation underscores the need for new treatments for T-cell lymphomas such as ATLL...

Continue reading

First Capital, Inc. Reports Quarterly Earnings

CORYDON, Ind., July 23, 2020 (GLOBE NEWSWIRE) — First Capital, Inc. (the “Company”) (NASDAQ:  FCAP), the holding company for First Harrison Bank (the “Bank”), today reported net income of $2.4 million or $0.73 per diluted share for the quarter ended June 30, 2020, compared to $2.9 million or $0.86 per diluted share for the quarter ended June 30, 2019.  The decrease was primarily due to a decrease in net interest income after provision for loan losses partially offset by an increase in noninterest income and a decrease in noninterest expense.Net interest income after provision for loan losses decreased $1.3 million for the quarter ended June 30, 2020 as compared to the same period in 2019.  Interest income decreased $845,000 when comparing the periods due to a decrease in the average tax-equivalent yield on interest-earning assets...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.